Atlas Trials

Shanghai AbelZeta Ltd.

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai AbelZeta Ltd.

RecordFirmDate
A Phase I Trial of A-CAR032 in Participants With mCRPC (NCT07344311)Shanghai AbelZeta Ltd.2026-01-13
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer (NCT07444281)Shanghai AbelZeta Ltd.2024-12-25
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC) (NCT06590246)Shanghai AbelZeta Ltd.2024-09-30
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma (NCT05800977)Shanghai AbelZeta Ltd.2023-02-22
Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis (NCT04208646)Shanghai AbelZeta Ltd.2020-05-16
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma (NCT03971747)Shanghai AbelZeta Ltd.2019-08-06
A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL (NCT03299738)Shanghai AbelZeta Ltd.2017-12-01

Track Shanghai AbelZeta Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.